Answer: Recommendations for patients at risk of sexually transmitted diseases
Explanation:
Regarding HPV infection, the patient must be included in the early detection program for cervical cancer, cervicovaginal cytology must be performed every year and, if positive, the management protocol will be followed regarding chlamydia infection and Gonorrhea, it should be reported that they are sexually transmitted diseases that can be avoided with the use of condoms and that it has the benefit that it is a method of barrier contraception, which apart from avoiding diseases such as those that it suffers, including HPV, which can lead to it to suffer cervical cancer and penile cancer in your partner, that although treatments have been developed, nowadays other illnesses that can be lethal like HIV or an unplanned conception can be avoided; for her reason for consultation, the patient and her partner should receive treatment, paying attention to return to the consultation if she has vaginal discharge that changes its appearance to the usual one with characteristics such as whitish lumps, fetid discharge with another coloration such as yellowish, greenish, grayish or bloody unrelated to the menstrual cycle, in addition to going if there is fever, pelvic or perineal pain or ulcerative or warty lesions in the pelvic region, as for your partner, you should go if you have a discharge of urethral flow, penile injuries such as ulcers, redness, excoriations, warts, fever or difficulty urinating, recommending both of them to carry out screening tests for HIV, syphilis and to verify the vaccination card for hepatitis B, once the procedures have been carried out, continue to encourage them to frequent the health service in programs of screening.
A. True. Any wearable used to prevent harm is considered PPE
ANSWER: CASE-CONTROL STUDY
EXPLANATION:
An epidemiology expert will make use of a Case-control Study for proper determination of association or linkage between the oil spill and the disease outbreak (arthritis).
Case-control Study provides an observational experiment between two existing groups (two reservoirs) differing in outcome (affected and not affected), they are highlighted and compared on the basis of a context (disease outbreak; arthritis).
However, the known group is regarded as the control group and it provides a substantial guide to the confirm the validity of other experimental groups in relation to the general context (outbreak of arthritis).
Adults—0.1 milligram (mg) two times a day, taken in the morning and at bedtime. Your doctor may adjust your dose as needed. The usual dose is 0.2 mg to 0.6 mg per day, divided and given two times a day.
can u pls explain the question a bit more clearly
